Q2 2017 · —
Revenue$15.36M$15.36M no prior Q2 2016 on file+3.4% vs Q1 2017
Net Income-$1.81M-$1.81M no prior Q2 2016 on fileN/M vs Q1 2017
EPS Diluted-$4.07-$4.07 no prior Q2 2016 on fileN/M vs Q1 2017
Margins · derived
Net margin-11.8%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2016 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sutro Biopharma, Inc. · CIK 1382101 · Engraved from SEC EDGAR